Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Shorla Oncology Introduced Novel SH-105 for the Treatment of Breast And Ovarian Cancer
Shorla Oncology has unveiled a groundbreaking drug, SH-105, designed to address breast and ovarian cancer. SH-105 marks a significant advancement as it offers a ready-to-dilute alternative
Vertex Pharmaceuticals Developed Ground Breaking CASGEVY™ Therapy for Sickle Cell Disease
Vertex Pharmaceuticals has pioneered CASGEVY™, a groundbreaking CRISPR/Cas9 gene-edited therapy designed to address sickle cell disease and transfusion-dependant beta thalassaemia
The University of Texas at El Paso Discovered New Thiophene F-8 for Leukaemia and Lymphoma Cancer Cells
Scientists at The University of Texas at El Paso have discovered a groundbreaking pharmaceutical compound, Thiophene F-8, which has demonstrated efficacy in eliminating leukaemia and lymphoma cancer cells.
CG Oncology Unveiled Novel Cretostimogene Grenadenorepvec for Non-Muscle Invasive Bladder Cancer
CG Oncology has introduced a new treatment cretostimogene grenadenorepvec for high-risk Bacillus Calmette-Guérin -unresponsive non-muscle invasive bladder cancer cases, particularly those with carcinoma in situ,
UC Davis Comprehensive Cancer Centre Developed New Gene Therapy for Liver Cancer
Researchers at UC Davis Comprehensive Cancer Centre have discovered a promising approach to combating hepatocellular carcinoma, a prevalent form of liver cancer. The study focused on inhibiting a specific protein called galectin
HKUMed Discovered Nanomedicine for Age-related Macular Degeneration (AMD) Therapy
The researchers from the University of Hong Kong, in partnership with the Zhongshan Ophthalmic Centre of Sun Yat-sen University, discovered a groundbreaking light-activatable prodrug nanomedicine for treating age-related macular degeneration
Blueprint Medicines Introduce AYVAKYT® First and Only Treatment for Indolent Systemic Mastocytosis
Blueprint Medicines has introduced AYVAKYT®, the first and only therapy for adults experiencing indolent systemic mastocytosis with moderate to severe symptoms that have not been effectively managed with current symptomatic treatments.
Roche Diagnostics Developed Novel Elecsys NfL Test for Multiple Sclerosis
Roche Diagnostics has developed a groundbreaking Elecsys NfL test, offering a crucial tool for individuals managing multiple sclerosis.
Bristol-Myers Squibb Discovered Abecma First CAR T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
Bristol-Myers Squibb has discovered Abecma® as a CAR T therapy for treating patients with relapsed or refractory multiple myeloma in Japan.
Osteal Therapeutics Developed Novel VT-X7 Therapy for the Treatment of Periprosthetic Joint Infection
Osteal Therapeutics has developed an innovative drug therapy, VT-X7, specifically designed to address periprosthetic joint infection affecting the hip and knee.
